Newron Pharmaceuticals
NWRN.SW
#8195
Rank
A$0.31 B
Marketcap
$16.13
Share price
-0.88%
Change (1 day)
17.64%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.71

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.71. In 2023 the company made an earnings per share (EPS) of -$1.71 a decrease over its 2022 EPS that were of -$1.67.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.712.03%
2022-$1.6715.39%
2021-$1.45-31.32%
2020-$2.1114.74%
2019-$1.8436.6%
2018-$1.35159.87%
2017-$0.52-67.81%
2016-$1.61-39.24%
2015-$2.65107.61%
2014-$1.2815.8%
2013-$1.10119.91%
2012-$0.50-66.51%
2011-$1.50-71.49%
2010-$5.25-10.83%
2009-$5.8942.06%
2008-$4.1556.53%
2007-$2.65-52.84%
2006-$5.62-188.53%
2005$6.34